Practical Applications and Considerations of Cell Surface Receptor Recombinant Proteins in the Development of In Vitro Diagnostic Reagents

Advantages of Recombinant Proteins as Calibrators and Quality Control Materials

In immunodiagnostic reagents, calibrators and quality control materials are core materials for ensuring the accuracy of test results. Cell surface receptor recombinant proteins, due to their high purity, well-defined structure, and stable source, are often used to replace natural antigens or purified proteins as reference materials for establishing calibration curves and routine quality control. Compared with natural extracts, recombinant proteins avoid limitations such as limited raw material sources and high batch-to-batch variability, helping to achieve standardization of detection systems.

For example, in tumor marker detection reagents, for the detection of specific cell surface receptors (such as EGFR, HER2, etc.), the use of recombinant proteins to prepare calibrators can better simulate the target characteristics in clinical samples. At the same time, recombinant proteins can also be used to prepare quality control materials to monitor the stability of reagents during storage and use. It should be noted that recombinant proteins used for diagnostic reagents should retain conformational epitopes consistent with natural proteins as much as possible; otherwise, detection specificity may be affected.

Applications in Immunohistochemistry and Flow Cytometry

Cell surface receptor recombinant proteins also play an important role in immunohistochemistry and flow cytometry. In immunohistochemistry method development, recombinant proteins can be used as standards for antigen adsorption experiments, to verify antibody specificity, and to assist in optimizing antibody dilution. In flow cytometry, fluorescently labeled recombinant receptor proteins can be used to establish positive controls or as tools for competitive inhibition experiments.

In addition, recombinant proteins can also be used to prepare porous microspheres or chips to construct multiplex detection platforms. For example, coupling multiple cell surface receptor recombinant proteins to encoded microspheres, combined with flow fluorescence detection technology, enables simultaneous analysis of autoantibody profiles against different receptors in serum. Such applications have high requirements for the stability and coupling efficiency of recombinant proteins. Common storage conditions are lyophilized powder or liquid form containing stabilizers, with storage temperature generally required to be -20°C or lower.

Role in the Diagnosis of Autoimmune Diseases

Patients with autoimmune diseases often produce antibodies against their own cell surface receptors, such as anti-acetylcholine receptor antibodies, anti-TSH receptor antibodies, etc. Recombinant receptor proteins as detection antigens can help establish specific ELISA or chemiluminescence detection methods. For example, coating microplates with recombinant acetylcholine receptor protein can be used for auxiliary diagnosis of patients with myasthenia gravis.

Since autoantibodies often recognize conformation-dependent epitopes, the expression system and folding method must be given key consideration when designing recombinant proteins. Recombinant proteins expressed in mammalian cells can usually form more correct disulfide bonds and glycosylation, making them more suitable as detection antigens. In reagent development, it is also necessary to verify the consistency of the immune response between recombinant proteins and natural receptors through clinical samples to ensure the clinical validity of test results.

Key Technical Points in Preparation and Validation

Cell surface receptor recombinant proteins used for in vitro diagnostics have special requirements in preparation and validation. The first is the choice of expression system: for receptors requiring complex post-translational modifications, mammalian cell systems are mostly used; for receptors with relatively simple structures, Escherichia coli or yeast systems can also be used, but subsequent refolding treatment must be noted. The second is the purification process, commonly using affinity chromatography combined with ion exchange or size exclusion chromatography, with the target product purity generally required to reach 95% or above.

In terms of validation, in addition to routine physicochemical analysis, immunoreactivity validation is also required. For example, binding experiments with known positive antibodies, parallel testing with clinical samples, etc. At the same time, stability study results should be able to support the maintenance of product activity within the labeled shelf life. The production process must also comply with the relevant requirements of the Good Manufacturing Practice for Medical Devices, ensuring that raw materials, processes, and environment meet the safety standards for biological materials used in medical devices.